뇌졸중 관리 시장 규모 조사 : 유형별, 용도별, 지역별 예측(2022-2032년)

Global Stroke Management Market is valued at approximately USD 37.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.40% over the forecast period 2024-2032. Stroke management refers to the comprehensive care and treatment provided to individuals who have experienced a stroke, a sudden interruption of blood flow to the brain. This interruption can be caused by a blockage in a blood vessel (ischemic stroke) or by the rupture of a blood vessel (hemorrhagic stroke). Stroke management involves a range of medical interventions and therapies aimed at preventing further damage to the brain, minimizing disability, and facilitating recovery. This may include emergency treatments such as clot-dissolving medications (thrombolytics) or procedures to remove clots, rehabilitation therapies such as physical therapy, speech therapy, and occupational therapy, medications to prevent future strokes, and lifestyle modifications to reduce risk factors such as high blood pressure, diabetes, and smoking. The goal of stroke management is to improve outcomes and quality of life for stroke survivors. The Global Stroke Management market is experiencing notable developments such as the rise of telemedicine and digital health solutions for remote stroke care, the integration of artificial intelligence (AI) and machine learning (ML) for early detection and personalised treatment and emphasising multidisciplinary stroke teams and comprehensive centres to improve coordination and intervention effectiveness. These developments highlight innovation, efficiency, and improved patient outcomes in stroke management.

Several crucial factors primarily propel the Global Stroke Management market. A key factor is advancements in medical technology, including telemedicine and digital health solutions, which facilitate remote evaluation and treatment of stroke patients, improving access to specialized care. Additionally, increased integration of artificial intelligence (AI) and machine learning (ML) algorithms in stroke care enhances early detection and personalized treatment plans, leading to better patient management. Moreover, the emphasis on multidisciplinary stroke teams and comprehensive stroke centres improves coordination among healthcare professionals, ensuring timely interventions and enhancing patient outcomes. However, the market also faces certain restraints. These include challenges related to regulatory frameworks governing telemedicine and digital health solutions and concerns about data privacy and security in AI-driven healthcare technologies. Additionally, the cost associated with implementing advanced stroke management technologies and the need for skilled professionals pose barriers to widespread adoption and optimal utilization of these innovations in the Global Stroke Management market.

The key regions considered for the global Stroke Management market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is a dominating region in the Global Stroke Management Market. The region due to its advanced healthcare infrastructure, robust research and development activities, and high adoption rates of innovative stroke management technologies. The region is driven by a large patient pool, increasing healthcare spending, and rising awareness about stroke prevention and treatment. Moreover, government initiatives and healthcare reforms aimed at improving access to healthcare services are further fueling market growth. With improving healthcare systems, rising awareness, and increasing adoption of innovative stroke management practices. North America's dominance in stroke care, offers substantial prospects for growth and advancement in the Global Stroke Management Market. The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

• Deepnoid Co., Ltd.
• B. Braun SE
• Aidoc Medical Ltd
• NeuraSignal, Inc.
• Boston Scientific Corporation
• Qure.ai Technologies Private Limited
• Brainomix Limited
• iSchemaView, Inc.
• Koninklijke Philips N.V
• Siemens AG

The detailed segments and sub-segment of the market are explained below:

By Type

• Diagnostics
• Therapeutics
• Software

By Application

• Ischemic Stroke
• Haemorrhagic Stroke

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• RoMEA

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Market Estimates & Forecast for 10 years from 2022 to 2032.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Stroke Management Market Definition and Research Assumptions

• 1.1. Research Objective
• 1.2. Market Definition
• 1.3. Research Assumptions
  • 1.3.1. Inclusion & Exclusion
  • 1.3.2. Limitations
  • 1.3.3. Supply Side Analysis
    • 1.3.3.1. Availability
    • 1.3.3.2. Infrastructure
    • 1.3.3.3. Regulatory Environment
    • 1.3.3.4. Market Competition
    • 1.3.3.5. Economic Viability (Consumer's Perspective)
  • 1.3.4. Demand Side Analysis
    • 1.3.4.1. Regulatory frameworks
    • 1.3.4.2. Technological Advancements
    • 1.3.4.3. Environmental Considerations
    • 1.3.4.4. Consumer Awareness & Acceptance
• 1.4. Estimation Methodology
• 1.5. Years Considered for the Study
• 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

• 2.1. Global Stroke Management Market Size & Forecast (2022- 2032)
• 2.2. Regional Summary
• 2.3. Segmental Summary
  • 2.3.1. By Type
  • 2.3.2. By Application
• 2.4. Key Trends
• 2.5. Recession Impact
• 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Stroke Management Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Challenges
• 3.3. Market Opportunities

Chapter 4. Global Stroke Management Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top investment opportunity
• 4.4. Top winning strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Stroke Management Market Size & Forecasts by Type 2022-2032

• 5.1. Diagnostics
• 5.2. Therapeutics
• 5.3. Software

Chapter 6. Global Stroke Management Market Size & Forecasts by Application 2022-2032

• 6.1. Ischemic Stroke
• 6.2. Haemorrhagic Stroke

Chapter 7. Global Stroke Management Market Size & Forecasts by Region 2022-2032

• 7.1. North America Stroke Management Market
  • 7.1.1. U.S. Stroke Management Market
    • 7.1.1.1. Type breakdown size & forecasts, 2022-2032
    • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
  • 7.1.2. Canada Stroke Management Market
• 7.2. Europe Stroke Management Market
  • 7.2.1. U.K. Stroke Management Market
  • 7.2.2. Germany Stroke Management Market
  • 7.2.3. France Stroke Management Market
  • 7.2.4. Spain Stroke Management Market
  • 7.2.5. Italy Stroke Management Market
  • 7.2.6. Rest of Europe Stroke Management Market
• 7.3. Asia-Pacific Stroke Management Market
  • 7.3.1. China Stroke Management Market
  • 7.3.2. India Stroke Management Market
  • 7.3.3. Japan Stroke Management Market
  • 7.3.4. Australia Stroke Management Market
  • 7.3.5. South Korea Stroke Management Market
  • 7.3.6. Rest of Asia Pacific Stroke Management Market
• 7.4. Latin America Stroke Management Market
  • 7.4.1. Brazil Stroke Management Market
  • 7.4.2. Mexico Stroke Management Market
  • 7.4.3. Rest of Latin America Stroke Management Market
• 7.5. Middle East & Africa Stroke Management Market
  • 7.5.1. Saudi Arabia Stroke Management Market
  • 7.5.2. South Africa Stroke Management Market
  • 7.5.3. Rest of Middle East & Africa Stroke Management Market

Chapter 8. Competitive Intelligence

• 8.1. Key Company SWOT Analysis
• 8.2. Top Market Strategies
• 8.3. Company Profiles
  • 8.3.1. Deepnoid Co., Ltd.
    • 8.3.1.1. Key Information
    • 8.3.1.2. Overview
    • 8.3.1.3. Financial (Subject to Data Availability)
    • 8.3.1.4. Product Summary
    • 8.3.1.5. Market Strategies
  • 8.3.2. B. Braun SE
  • 8.3.3. Aidoc Medical Ltd
  • 8.3.4. NeuraSignal, Inc.
  • 8.3.5. Boston Scientific Corporation
  • 8.3.6. Qure.ai Technologies Private Limited
  • 8.3.7. Brainomix Limited
  • 8.3.8. iSchemaView, Inc.
  • 8.3.9. Koninklijke Philips N.V
  • 8.3.10. Siemens AG

Chapter 9. Research Process

• 9.1. Research Process
  • 9.1.1. Data Mining
  • 9.1.2. Analysis
  • 9.1.3. Market Estimation
  • 9.1.4. Validation
  • 9.1.5. Publishing
• 9.2. Research Attributes